Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication May 12, 2004
- Accepted for publication October 22, 2004
- Published online January 24, 2005.
Article Versions
- Earlier version (December 8, 2004 - 06:54).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2005 American Society of Nephrology
Author Information
- Marie-Agnès Dragon-Durey*,
- Chantal Loirat†,
- Sylvie Cloarec‡,
- Marie-Alice Macher†,
- Jacques Blouin*,
- Hubert Nivet‡,
- Laurence Weiss§,
- Wolf Herman Fridman*‖ and
- Véronique Frémeaux-Bacchi*‖
- *Service d’Immunologie Biologique, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris; †Service de Néphrologie, Hôpital Robert Debré, Assistance Publique-Hôpitaux de Paris, Paris; ‡Unité de Néphrologie Pédiatrique, Centre Hospitalier de Tours, Tours; §Service d’Immunologie Clinique, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris; and ‖INSERM U255, Institut des Cordeliers, Paris, France
- Address correspondence to:
Dr. Marie-Agnès Dragon-Durey, Service d’Immunologie Biologique, Hôpital Européen Georges Pompidou, 20 rue Leblanc, 75 015 Paris, France. Phone: 33-1-56-09-39-41; Fax: 33-1-56-09-20-80; E-mail: marie-agnes.durey{at}egp.ap-hop-paris.fr
Statistics from Altmetric.com
Article usage
Cited By...
Anti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome
Jump to section
More in this TOC Section
Cited By...
- Anti-Factor H Antibody Reactivity in Young Adults Vaccinated with a Meningococcal Serogroup B Vaccine Containing Factor H Binding Protein
- Potentiation of complement regulator factor H protects human endothelial cells from complement attack in aHUS sera
- C5b9 Formation on Endothelial Cells Reflects Complement Defects among Patients with Renal Thrombotic Microangiopathy and Severe Hypertension
- Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy: A Case Series
- Thrombotic Microangiopathy and the Kidney
- HUS and atypical HUS
- FHR3 Blocks C3d-Mediated Coactivation of Human B Cells
- Complement Factor H-Related 5-Hybrid Proteins Anchor Properdin and Activate Complement at Self-Surfaces
- Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis
- Factor H Autoantibodies in Patients with Antiphospholipid Syndrome and Thrombosis
- Current Understanding of the Role of Complement in IgA Nephropathy
- Anti-Factor H Autoantibodies in C3 Glomerulopathies and in Atypical Hemolytic Uremic Syndrome: One Target, Two Diseases
- The Major Autoantibody Epitope on Factor H in Atypical Hemolytic Uremic Syndrome Is Structurally Different from Its Homologous Site in Factor H-related Protein 1, Supporting a Novel Model for Induction of Autoimmunity in This Disease
- Loss of DGK{varepsilon} induces endothelial cell activation and death independently of complement activation
- A Novel Atypical Hemolytic Uremic Syndrome-Associated Hybrid CFHR1/CFH Gene Encoding a Fusion Protein That Antagonizes Factor H-Dependent Complement Regulation
- Protecting the kidney from complement: atypical haemolytic uraemic syndrome
- Complement Mutations in Diacylglycerol Kinase-{varepsilon}-Associated Atypical Hemolytic Uremic Syndrome
- Human Factor H (FH) Impairs Protective Meningococcal Anti-FHbp Antibody Responses and the Antibodies Enhance FH Binding
- Phenotypic Expansion of DGKE-Associated Diseases
- Complement Factor H-Related Protein 1 Deficiency and Factor H Antibodies in Pediatric Patients with Atypical Hemolytic Uremic Syndrome
- Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical Phenotype
- Overall Neutralization of Complement Factor H by Autoantibodies in the Acute Phase of the Autoimmune Form of Atypical Hemolytic Uremic Syndrome
- Atypical Hemolytic Uremic Syndrome-Associated Variants and Autoantibodies Impair Binding of Factor H and Factor H-Related Protein 1 to Pentraxin 3
- Factor I Autoantibodies in Patients with Atypical Hemolytic Uremic Syndrome: Disease-Associated or an Epiphenomenon?
- A Novel C3 Mutation Causing Increased Formation of the C3 Convertase in Familial Atypical Hemolytic Uremic Syndrome
- Glomerulonephritis With Isolated C3 Deposits and Monoclonal Gammopathy: A Fortuitous Association?
- Allelic Variants of Complement Genes Associated with Dense Deposit Disease
- Disease-associated N-terminal Complement Factor H Mutations Perturb Cofactor and Decay-accelerating Activities
- Clinical Features of Anti-Factor H Autoantibody-Associated Hemolytic Uremic Syndrome
- Complement Factor H Autoantibodies and Age-Related Macular Degeneration
- Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype
- An Allelic Variant of Crry in the Murine Sle1c Lupus Susceptibility Interval Is Not Impaired in Its Ability To Regulate Complement Activation
- Complement Factor H Autoantibodies Are Associated with Early Stage NSCLC
- Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome
- aHUS: a disorder with many risk factors
- Platelet-associated complement factor H in healthy persons and patients with atypical HUS
- Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome
- A Large Family with a Gain-of-Function Mutation of Complement C3 Predisposing to Atypical Hemolytic Uremic Syndrome, Microhematuria, Hypertension and Chronic Renal Failure
- Complement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome
- The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome
- Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome
- Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation
- The Complement Factor H R1210C Mutation Is Associated With Atypical Hemolytic Uremic Syndrome
- Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency
- Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome
- Differential Impact of Complement Mutations on Clinical Characteristics in Atypical Hemolytic Uremic Syndrome
- Screening for Complement System Abnormalities in Patients with Atypical Hemolytic Uremic Syndrome
- Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome
- Hemolytic Uremic Syndrome: A Factor H Mutation (E1172Stop) Causes Defective Complement Control at the Surface of Endothelial Cells
- Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome
- Genetic and Functional Analyses of Membrane Cofactor Protein (CD46) Mutations in Atypical Hemolytic Uremic Syndrome
- The Central Role of the Alternative Complement Pathway in Human Disease
- Factor H and Atypical Hemolytic Uremic Syndrome: Mutations in the C-Terminus Cause Structural Changes and Defective Recognition Functions
- Outcome of Renal Transplantation in Patients with Non-Shiga Toxin-Associated Hemolytic Uremic Syndrome: Prognostic Significance of Genetic Background
- Hemolytic Uremic Syndrome